BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26201035)

  • 61. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
    Enshaei A; O'Connor D; Bartram J; Hancock J; Harrison CJ; Hough R; Samarasinghe S; den Boer ML; Boer JM; de Groot-Kruseman HA; Marquart HV; Noren-Nystrom U; Schmiegelow K; Schwab C; Horstmann MA; Escherich G; Heyman M; Pieters R; Vora A; Moppett J; Moorman AV
    Blood; 2020 Apr; 135(17):1438-1446. PubMed ID: 32315382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia.
    Pushpam D; Chopra A; Sreenivas V; Kumar R; Bakhshi S
    Indian Pediatr; 2019 May; 56(5):381-383. PubMed ID: 30898988
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt.
    Hussein H; Sidhom I; Naga SA; Amin M; Ebied E; Khairy A; Kamel A; El-Sharkawy N
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):507-14. PubMed ID: 15284589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of chemotherapy-related hyperglycemia on prognosis of child acute lymphocytic leukemia.
    Zhang BH; Wang J; Xue HM; Chen C
    Asian Pac J Cancer Prev; 2014; 15(20):8855-9. PubMed ID: 25374219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia.
    Zhang Y; Dai K; Zhang Q; Huang Y; Feng Y; Bhardwaj D; Yu K; Feng J
    Cancer Invest; 2021; 39(6-7):550-558. PubMed ID: 34027748
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
    Zeidler L; Zimmermann M; Möricke A; Meissner B; Bartels D; Tschan C; Schrauder A; Cario G; Goudeva L; Jäger S; Ratei R; Ludwig WD; Teigler-Schlegel A; Skokowa J; Koehler R; Bartram CR; Riehm H; Schrappe M; Welte K; Stanulla M
    Haematologica; 2012 Mar; 97(3):402-9. PubMed ID: 22058224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pediatric Medical Care System in China Has Significantly Reduced Abandonment of Acute Lymphoblastic Leukemia Treatment.
    Zhou Q; Hong D; Lu J; Zheng D; Ashwani N; Hu S
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):181-4. PubMed ID: 25393454
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.
    Bar M; Othus M; Park HM; Sandhu V; Chen X; Wood BL; Estey E
    Leuk Lymphoma; 2015; 56(11):3109-15. PubMed ID: 25726954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is testicular irradiation necessary for patients with acute lymphoblastic leukemia and testicular relapse?
    Pui CH
    Pediatr Blood Cancer; 2018 May; 65(5):e26977. PubMed ID: 29350461
    [No Abstract]   [Full Text] [Related]  

  • 70. Serum levels and differential expression of intercellular adhesion molecule-1 in childhood leukemia and malignant lymphoma: prognostic importance and relationship with survival.
    Tacyildiz N; Yavuz G; Gozdasoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Ensari A; Okcuoglu-Cavdar A
    Pediatr Hematol Oncol; 1999; 16(2):149-58. PubMed ID: 10100275
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
    Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
    [No Abstract]   [Full Text] [Related]  

  • 72. Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia.
    Gurunathan A; Desai AV; Bailey LC; Li Y; Choi JK; Rheingold SR
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27433. PubMed ID: 30207055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Do traumatic lumbar punctures lead to greater relapses in acute lymphoblastic leukemia? Experience at a university hospital in India.
    Totadri S; Trehan A; Srinivasan R; Bansal D; Bhatia P
    Indian J Cancer; 2015; 52(3):300-3. PubMed ID: 26905118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flow Cytometry-based Absolute Blast Count on Day 8: Reliable, Fast, and Inexpensive Method.
    Aycicek A; Pasli Uysalol E; Tahtakesen TN; Ozdemir GN; Akici F; Bayram C
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):33. PubMed ID: 32459717
    [No Abstract]   [Full Text] [Related]  

  • 75. [Prognostic factors of childhood acute lymphoblastic leukemia].
    Ye H; Gu LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):586-9. PubMed ID: 12513729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
    Thastrup M; Marquart HV; Levinsen M; Grell K; Abrahamsson J; Albertsen BK; Frandsen TL; Harila-Saari A; Lähteenmäki PM; Niinimäki R; Pronk CJ; Ulvmoen A; Vaitkevičienė G; Taskinen M; Schmiegelow K;
    Leukemia; 2020 Feb; 34(2):336-346. PubMed ID: 31534171
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse.
    Advani A; Jin T; Bolwell B; Copelan E; Sekeres M; Sobecks R; Sungren S; Yurch M; Kalaycio M
    Leuk Lymphoma; 2009 Jul; 50(7):1126-31. PubMed ID: 19557633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sexual Dimorphism in Children and Adolescents With Acute Lymphoblastic Leukemia: Influence on Incidence and Survival.
    Jaime-Pérez JC; Hernández-De Los Santos JA; Fernández LT; Padilla-Medina JR; Gómez-Almaguer D
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e293-e298. PubMed ID: 31725540
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia.
    Damlaj M; Ghazi S; Mashaqbeh W; Gmati G; Salama H; Abuelgasim KA; Rather M; Hajeer A; Al-Zahrani M; Jazieh AR; Alhejazi A; Alaskar A
    World J Transplant; 2017 Aug; 7(4):235-242. PubMed ID: 28900606
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
    Molina JC; Li Y; Otto WR; Miller TP; Getz KD; Mccoubrey C; Ramos M; Krause E; Cao L; Gramatges MM; Rabin K; Scheurer M; Elgarten CW; Myers RM; Seif AE; Fisher BT; Shah NN; Aplenc R
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30062. PubMed ID: 36370087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.